Expression of the PTEN tumour suppressor protein during human development

Human Molecular Genetics

Volumn 9, Issue 11, 2000, Pages 1633-1639

  Gimm, Oliver ^a   Attié Bitach, Tania ^b   Lees, Jacqueline A ^c   Vekemans, Michel ^b   Eng, Charis ^a,d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHATASE; RNA;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KNOCKOUT GENE; PERIPHERAL NERVOUS SYSTEM; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SKIN; THYROID GLAND; TUMOR SUPPRESSOR GENE;

EID: 18844472952     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.11.1633     Document Type: Article

References (64)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Pue, J., Miliaresis, C., Rodgers, L., McCombie, R. et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [see comments]. Science, 275, 1943-1947.
2. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T. et al. (1997) Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet., 15, 356-362.
3. Li, D.M. and Sun, H. (1997) TEPl, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res., 57, 2124-2129.
4. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M. et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet., 16, 64-67.
5. Marsh, D.J., Dahia, P.L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R.J. and Eng, C. (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet., 16, 333-334.
6. Marsh, D.J., Coulon, V., Lunetta, K.L., Rocca-Serra, P., Dahia, P.L., Zheng, Z., Liaw, D., Caron, S., Duboue, B., Lin, A.Y. et al. (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet., 7, 507-515.
7. Marsh, D.J., Kum, J.B., Lunetta, K.L., Bennett, M.J., Gorlin, R.J., Ahmed, S.F., Bodurtha, J., Crowe, C., Curtis, M.A., Dasouki, M. et al. (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet., 8, 1461-1472.
8. Zhou, X.P., Marsh, D.J., Hampel, H., Mulliken, J.B., Gimm, O. and Eng, C. (2000) Germline and germline mosaic PTEN mutations associated with Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arterio-venous malformations and lipomatosis. Hum. Mol. Genet., 9, 765-768.
9. Wang, S.I., Pue, J., Li, J., Bruce, J.N., Cairns, P., Sidransky, D. and Parsons, R. (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res., 57, 4183-4186.
10. Rasheed, B.K., Stenzel, T.T., McLendon, R.E., Parsons, R., Friedman, A.H., Friedman, H.S., Bigner, D.D. and Bigner, S.H. (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res., 57, 4187-4190.
11. Risinger, J.I., Hayes, A.K., Berchuck, A. and Barrett, J.C. (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57, 4736-4738.
12. Teng, D.H., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K.L., Vinson, V.L., Gumpper, K.L. et al. (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57, 5221-5225.
13. Nelen, M.R., Padberg, G.W., Peeters, E.A., Lin, A.Y., van den Helm, B., Frants, R.R., Coulon, V., Goldstein, A.M., van Reen, M.M., Easton, D.F. et al. (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nature Genet., 13, 114-116.
14. Eng, C. (1997) Cowden Syndrome. J. Genet. Counsel., 6, 181-192.
15. Furnari, F.B., Huang, H.J. and Cavenee, W.K. (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res., 58, 5002-5008.
16. Li, D.M. and Sun, H. (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl Acad. Sci. USA, 95, 15406-15411.
17. Weng, L.P., Smith, W.M., Dahia, P.L., Ziebold, U., Gil, E., Lees, J.A. and Eng, C. (1999) PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res., 59, 5808-5814.
18. Gu, J., Tamura, M. and Yamada, K.M. (1998) Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol., 143, 1375-1383.
19. Tamura, M., Gu, J., Matsumoto, K., Aota. S., Parsons, R. and Yamada, K.M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617.
20. Kremer, H., Nelen, M., Schepens, J., Hendrik, W. and Padberg, G. (1999) PTEN transcription in mouse development. Am. J. Hum. Genet., 65 (Suppl.), A134.
21. Luukko, K., Ylikorkala, A., Tiainen, M. and Makela, T.P. (1999) Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech. Dev., 83, 187-190.
22. Dahia, P.L., FitzGerald, M.G., Zhang, X., Marsh, D.J., Zheng, Z., Pietsch, T., von Deimling, A., Haluska, F.G., Haber, D.A. and Eng, C. (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16, 2403-2406.
23. Forgacs, E., Biesterveld, E.J., Sekido, Y., Fong, K., Muneer, S., Wistuba, II, Milchgrub, S., Brezinschek, R., Virmani, A., Gazdar, A.F. et al. (1998) Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene, 17, 1557-1565.
24. Whang, Y.E., Wu, X. and Sawyers, C.L. (1998) Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene. J. Natl Cancer Inst., 90, 859-861.
25. Fujii, G.H., Morimoto, A.M., Berson, A.E. and Bolen, J.B. (1999) Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene, 18, 1765-1769.
26. Liu, J. and Kagan, J. (1999) Method to distinguish between the MMAC1/PTEN gene and its pseudogene in RT-PCR analysis of point mutations. Biotechniques, 26, 19-22, 24.
27. Fougerousse, F., Bullen, P., Herasse, M., Lindsay, S., Richard, I., Wilson, D., Suel, L., Durand, M., Robson, S., Abitbol, M. et al. (2000) Humanmouse differences in the embryonic expression patterns of developmental control genes and disease genes. Hum. Mol. Genet., 9, 165-173.
28. Duerr, E.M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlilz, B., Louis, D.N., Schramm, J., Wiestler, O.D., Parsons, R., Eng, C. et al. (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene, 16, 2259-2264.
29. Eng. C. (1998) Genetics of Cowden syndrome: through the looking glass of oncology. Int. J. Oncol., 12, 701-710.
30. Saul, R.A., Stevenson, R.E. and Bley, R. (1982) Mental retardation in the Bannayan syndrome. Pediatrics, 69, 642-644.
31. Fargnoli, M.C., Orlow, S.J., Semel-Concepcion, J. and Bolognia, J.L. (1996) Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch. Dermatol., 132, 1214-1218.
32. Liu, W., James, C.D., Frederick, L., Alderete, B.E. and Jenkins, R.B. (1997) PTEM/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res., 57, 5254-5257.
33. Fults, D., Pedone, C.A., Thompson, G.E., Uchiyama, C.M., Gumpper, K.L., Iliev, D., Vinson, V.L., Tavtigian, S.V. and Perry III, W.L. (1998) Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXII in human glioblastoma multiforme. Int. J. Oncol., 12, 905-910.
34. Zhou, X.P., Li, Y.J., Hoang-Xuan, K., Laurent-Puig, P., Mokhtari, K., Longy, M., Sanson, M., Delattre, J.Y., Thomas, G. and Hamelin, R. (1999) Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int. J. Cancer, 84, 150-154.
35. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P.P. (1998) Pten is essential for embryonic development and tumour suppression. Nature Genet., 19, 348-355.
36. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W. et al. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol., 8, 1169-1178.
37. Podsypanina, K., Ellenson, L.H., Nemes, A., Gu, J., Tamura, M., Yamada, K.M., Cordon-Cardo, C., Catoretti, G., Fisher, P.E. and Parsons, R. (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA, 96, 1563-1568.
38. Eng, C. and Parsons, R. (1998) Cowden syndrome. In Vogelstein, B. and Kinzler, K.W. (eds), The Genetic Basis of Human Cancer. McGraw-Hill, New York, NY, pp. 519-526.
39. Lashner, B.A., Riddell, R.H. and Winans, C.S. (1986) Ganglioneuromatosis of the colon and extensive glycogenic acanthosis in Cowden's disease. Dig. Dis. Sci., 31, 213-216.
40. Gimm, O., Perren, A., Weng, L.P., Marsh, D.J., Yeh, J.J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J.A. et al. (2000) Differential nuclear and cyloplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol., 156, 1693-1700.
41. Dahia, P.L., Marsh, D.J., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R., Longy, M., Larsson, C. et al. (1997) Somaticdeletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res., 57, 4710-4713.
42. Halachmi, N., Halachmi, S., Evron, E., Cairns, P., Okami, K., Saji, M., Westra, W.H., Zeiger, M.A., Jen, J. and Sidransky, D. (1998) Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer, 23, 239-243.
43. Marsh, D.J., Zheng, Z., Zedenius, J., Kremer, H., Padberg, G.W., Larsson, C., Longy, M. and Eng, C. (1997) Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res., 57, 500-503.
44. Starink, T.M. (1984) Cowden's disease: analysis of fourteen new cases. J. Am. Acad. Dermatol., 11, 1127-1141.
45. Haggitt, R.C. and Reid, B.J. (1986) Hereditary gastrointestinal polyposis syndromes. Am. J. Surg. Pathol., 10, 871-887.
46. Hover, A.R., Cawthern, T. and McDanial, W. (1986) Cowden disease. A hereditary polyposis syndrome diagnosable by mucocutaneous inspection. J. Clin. Gastroenterol., 8, 576-579.
47. Guanti, G., Resta, N., Simone, C., Cariola, F., Demma, I., Fiorente, P. and Gentile, M. (2000) Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum. Mol. Genet., 9, 283-287.
48. Wang, Z.J., Taylor, F., Churchman, M., Norbury, G. and Tomlinson, I. (1998) Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am. J. Pathol., 153, 363-366.
49. Chang, J.G., Chen, Y.J., Perng, L.I., Wang, N.M., Kao, M.C., Yang, T.Y., Chang, C.P. and Tsai, C.H. (1999) Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract. Eur. J. Cancer, 35, 647-651.
50. Yao, YJ., Ping, X.L., Zhang, H., Chen, F.F., Lee, P.K., Ahsan, H., Chen, C.J., Lee, P.H., Peacocke, M., Santella, R.M. et al. (1999) PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene, 18, 3181-3185.
51. Sakurada, A., Suzuki, A., Sato, M., Yamakawa, H., Orikasa, K., Uyeno, S., Ono, T., Ohuchi, N., Fujimuru, S. and Horii, A. (1997) Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung. pancreas, kidney, and ovary. Jpn J. Cancer., 88, 1025-1028.
52. Hahn, M., Wieland, I., Koufaki, O.N., Gorgens, H., Sobottka, S.B., Schackert, G. and Schackert, H.K. (1999) Genetic alterations of the tumor suppressor gene PTKN/MMAC1 in human brain metastases. Clin. Cancer Res., 5, 2431-2437.
53. Perren, A., Weng, L.P., Boag, A.H., Ziebold, U., Thakore, K., Dahia, P.L., Komminoth, P., Lees, J.A., Mulligan, L.M., Mutter, G.L. et al. (1999) Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol., 155, 1253-1260.
54. Longy, M., Coulon, V., Duboue, B., David, A., Larregue, M., Eng. C., Amati, P., Kraimps, J.L., Bottani, A., Lacombe. D. et al. (1998) Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype. J. Med. Genet., 35, 886-889.
55. Jiang, B.H., Zheng, J.Z., Aoki, M. and Vogt, P.K. (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl Acad. Sci. USA, 97, 1749-1753.
56. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P. and Mak, T.W. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39.
57. Desai, D.C., Murday, V., Phillips, R.K., Neale, K.F., Milla, P. and Hodgson, S.V. (1998) A survey of phenotypic features in juvenile polyposis. J. Med. Genet., 35, 476-481.
58. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J.G., Jen, J., Isaacs, W.B., Bova, G.S. and Sidransky, D. (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000.
59. Tashiro, H., Blazes, M.S., Wu, R., Cho, K.R., Bose. S., Wang, S.I., Li, J., Parsons, R. and Ellenson, L.H. (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940.
60. Yoshinaga, K., Sasano, H., Furukawa, T., Yamakawa, H., Yuki, M., Sato, S., Yajima, A. and Horii, A. (1998) The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn J. Cancer Res., 89, 985-990.
61. Dahia, P.L., Aguiar, R.C., Alberta, J., Kum, J.B., Caron, S., Sill, H., Marsh, D.J., Ritz, J., Freedman, A., Stiles, C. et al. (1999) PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum. Mol. Genet., 8, 185-193.
62. Halevy, S., Sandbank, M., Pick, A.I. and Feuerman, E.J. (1985) Cowden's disease in three siblings: electron-microscope and immunological studies. Acta Derm. Venereol., 65, 126-131.
63. O'Hare, A.M., Cooper, P.H. and Parlette III, H.L. (1997) Trichilemmomal carcinoma in a patient with Cowden's disease (multiple hamartoma syndrome). J. Am. Acad. Dermatol., 36, 1021-1023.
64. Attie-Bitach, T., Abitbol, M., Gerard, M., Delezoide, A.L., Auge, J., Pelet, A., Amiel, J., Pachnis, V., Munnich, A., Lyonnet, S. et al. (1998) Expression of the RET proto-oncogene in human embryos. Am. J. Med. Genet., 80, 481-486.